Accendra Health Inc (ACH) stock
ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3098% below fair value
$0.13−0.02 (-13.33%)
Close on Nov 13, 2026Market cap $10.00MP/E –Yield –
Accendra Health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Accendra Health's revenue for the twelve months ending Sep 30, 2026 was $2.55B, down 7.1% year over year. For fiscal 2025 it was $2.76B, up 3.1% from the year before. Over ten years it grew -11.9% a year on average. The highest annual figure on record is $9.96B in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.76B | +3.1% |
| FY2024 | Dec 31, 2024 | $2.68B | +5.0% |
| FY2023 | Dec 31, 2023 | $2.55B | -74.4% |
| FY2022 | Dec 31, 2022 | $9.96B | +1.7% |
| FY2021 | Dec 31, 2021 | $9.79B | +15.4% |
| FY2020 | Dec 31, 2020 | $8.48B | -7.9% |
| FY2019 | Dec 31, 2019 | $9.21B | -2.2% |
| FY2018 | Dec 31, 2018 | $9.42B | +1.1% |
| FY2017 | Dec 31, 2017 | $9.32B | -4.2% |
| FY2016 | Dec 31, 2016 | $9.72B | -0.5% |
| FY2015 | Dec 31, 2015 | $9.77B | +3.5% |
| FY2014 | Dec 31, 2014 | $9.44B | +4.1% |
| FY2013 | Dec 31, 2013 | $9.07B | +2.3% |
| FY2012 | Dec 31, 2012 | $8.87B | +2.8% |
| FY2011 | Dec 31, 2011 | $8.63B | +6.2% |
| FY2010 | Dec 31, 2010 | $8.12B | +1.1% |
| FY2009 | Dec 31, 2009 | $8.04B | +11.0% |
| FY2008 | Dec 31, 2008 | $7.24B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $601.78M | -13.7% |
| Q2 FY2026 | Jun 30, 2026 | $613.23M | -10.1% |
| Q1 FY2026 | Mar 31, 2026 | $627.78M | -6.8% |
| Q4 FY2025 | Dec 31, 2025 | $708.97M | +2.0% |
| Q3 FY2025 | Sep 30, 2025 | $697.26M | +1.5% |
| Q2 FY2025 | Jun 30, 2025 | $681.92M | +3.3% |
| Q1 FY2025 | Mar 31, 2025 | $673.88M | -74.2% |
| Q4 FY2024 | Dec 31, 2024 | $695.02M | -73.8% |
| Q3 FY2024 | Sep 30, 2024 | $686.85M | -73.5% |
| Q2 FY2024 | Jun 30, 2024 | $660.40M | -74.2% |
| Q1 FY2024 | Mar 31, 2024 | $2.61B | +3.6% |
| Q4 FY2023 | Dec 31, 2023 | $2.66B | +4.1% |
| Q3 FY2023 | Sep 30, 2023 | $2.59B | +3.8% |
| Q2 FY2023 | Jun 30, 2023 | $2.56B | +2.5% |
| Q1 FY2023 | Mar 31, 2023 | $2.52B | +4.8% |
| Q4 FY2022 | Dec 31, 2022 | $2.55B | +3.4% |
| Q3 FY2022 | Sep 30, 2022 | $2.50B | -0.2% |
| Q2 FY2022 | Jun 30, 2022 | $2.50B | +0.4% |
| Q1 FY2022 | Mar 31, 2022 | $2.41B | +3.5% |
| Q4 FY2021 | Dec 31, 2021 | $2.47B | +4.5% |
| Q3 FY2021 | Sep 30, 2021 | $2.50B | +14.4% |
| Q2 FY2021 | Jun 30, 2021 | $2.49B | +37.7% |
| Q1 FY2021 | Mar 31, 2021 | $2.33B | +9.6% |
| Q4 FY2020 | Dec 31, 2020 | $2.36B | +7.8% |
| Q3 FY2020 | Sep 30, 2020 | $2.19B | -4.6% |
| Q2 FY2020 | Jun 30, 2020 | $1.81B | -23.9% |
| Q1 FY2020 | Mar 31, 2020 | $2.12B | -9.7% |
| Q4 FY2019 | Dec 31, 2019 | $2.19B | +3.2% |
| Q3 FY2019 | Sep 30, 2019 | $2.29B | -7.0% |
| Q2 FY2019 | Jun 30, 2019 | $2.38B | -3.3% |
| Q1 FY2019 | Mar 31, 2019 | $2.35B | -0.9% |
| Q4 FY2018 | Dec 31, 2018 | $2.12B | -11.2% |
| Q3 FY2018 | Sep 30, 2018 | $2.46B | +5.6% |
| Q2 FY2018 | Jun 30, 2018 | $2.46B | +8.5% |
| Q1 FY2018 | Mar 31, 2018 | $2.37B | +1.9% |
| Q4 FY2017 | Dec 31, 2017 | $2.39B | +0.9% |
| Q3 FY2017 | Sep 30, 2017 | $2.33B | – |
| Q2 FY2017 | Jun 30, 2017 | $2.27B | – |
| Q1 FY2017 | Mar 31, 2017 | $2.33B | – |
| Q4 FY2016 | Dec 31, 2016 | $2.37B | – |
See a number that looks wrong?